DocGo (DCGO) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts DCGO Hot Sheet
Join SI Premium – FREE
DocGo (NASDAQ: DCGO) reported Q2 EPS of $0.11, $0.07 better than the analyst estimate of $0.04. Revenue for the quarter came in at $109.5 million versus the consensus estimate of $97.94 million.
GUIDANCE:
DocGo sees FY2022 revenue of $425-435 million, versus the consensus of $411.4 million.
For earnings history and earnings-related data on DocGo (DCGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Waystar Holding Corp. (WAY) Reports Q3 EPS of $0.44
- aTyr Pharma (LIFE) Reports Q3 EPS of $0.53; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
